Lawsuit against DEA for denying psilocybin access rejected
Federal Appeals Court Dismisses Cancer Patients’ Case To Use Psilocybin Under Right-To-Try Laws A lawsuit
February 1, 2022
Federal Appeals Court Dismisses Cancer Patients’ Case To Use Psilocybin Under Right-To-Try Laws A lawsuit
Braxia Scientific Provides Update on Large Proprietary Dataset Expected to Support Pharmaceutical and Industry Clinical
Filament Health and Cybin Therapeutics Announce Approval for Phase II Clinical Trial for Depression Trial
Lexston Life Sciences Is Granted Section 56 Exemption From Health Canada and Embarks on the
Decreases in Suicidality Following Psychedelic Therapy: A Meta-Analysis of Individual Patient Data Across Clinical Trials
Red Light Holland’s Partner CCrest Laboratories Approved By Health Canada to Supply Psilocybin to the
Nova Mentis and KGK Science Form Tactical Partnership The Companies Plan to Jointly Submit a
Numinus Identified as a Licensed Psilocybin Supplier by Health Canada Health Canada list identifies select companies that
Wellbeing Digital Sciences’ Subsidiary KGK Science Forms Tactical Partnership with Nova Mentis The Companies Plan
Mindset Pharma Enters Manufacturing Agreement with Leading CDMO to Produce Pharmaceutical Grade Batches of Next-Generation
Core One Labs Announces Successful Proof of Concept and Files Patent for Protection of its
Lexston Announces the Launch of a Psychedelic Mushrooms Genetic Identification Test Vancouver, British Columbia, January
Controversial Kansas Lawmaker Files Bill To Legalize Psilocybin Possession And Cultivation A Kansas legislator filed
Two thirds of physicians surveyed believe psilocybin therapy has potential benefit for patients with treatment-resistant
Survey Finds Majority of Affected Americans Approve of Psychedelics as an Alternative Treatment to Address
Sydney Researchers Awarded Over $2.2 Million By Australian Government To Study MDMA, Psilocybin University of
Optimi Health Submits Natural Psilocybin Combined Drug Delivery and Extraction Formulations for Provisional Patent Company
Red Light Holland to Collaborate with Advocacy Group, Psychedelic Medicine Alliance Washington to Promote Proposed
Wesana Health Announces Positive Findings From Animal Study on Novel Depression Treatment Protocol Combining Psilocybin
Telescope Files Patent Cooperation Treaty Application on Scalable Psilocybin and Tryptamine Synthesis Vancouver, BC —
Revive Therapeutics Provides Update of Psilocybin Pharmaceutical Programs IRB approval to initiate Phase 2 study
Numinus Submits Clinical Trial Application for Phase 1 Trial on Proprietary Psilocybin Product The trial
Filament Health and Cybin Therapeutics Announce Licensing Agreement Filament will license PEX010, its proprietary botanical
Mydecine to Launch Special Access Support and Supply Program in Canada Expanding Access to Psychedelic-Assisted